Klorhexidinsprit Farget Fresenius Kabi

Chlorhexidine gluconate, the active ingredient in Klorhexidinsprit Farget, is an antiseptic presented as a solution for cutaneous use. It is employed to reduce microbial presence on the skin before procedures and to cleanse wounds in various patient populations.

GNH USA supplies Klorhexidinsprit Farget as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Klorhexidinsprit Farget is used as a topical antiseptic for skin and wound management.

- Skin antisepsis: Reduces resident and transient flora on intact skin prior to invasive procedures. - Pre‑operative skin preparation: Provides rapid, broad‑spectrum antimicrobial action to lower surgical site infection risk. - Wound cleansing: Helps cleanse contaminated wounds and minor abrasions, supporting the body’s natural healing process.

Chlorhexidine gluconate may cause local adverse reactions, ranging from mild irritation to rare severe events.

Common Side Effects: - Skin irritation: mild redness or burning at the application site. - Itching: transient pruritus following exposure. - Dryness: temporary loss of skin moisture. - Stinging sensation: brief discomfort upon contact.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, or blistering. - Anaphylaxis: systemic allergic reaction with respiratory distress, rare but life‑threatening. - Chemical burns: deep tissue injury with prolonged exposure or high concentration. - Contact urticaria: hives developing at the site of application.

When using Klorhexidinsprit Farget, observe the following precautions to ensure safe and effective application.

- Allergy assessment: avoid use in patients with known hypersensitivity to chlorhexidine or related compounds. - Application area: limit to intact skin unless directed for wound cleansing; do not apply to mucous membranes. - Duration of contact: follow recommended exposure time; excessive prolonged contact may increase irritation risk. - Pediatric use: exercise caution in infants and young children; consult a healthcare professional before use. - Interaction with latex: be aware of possible cross‑reactivity in patients with latex allergy. - Store at ambient temperature: keep the product below 25 °C, in the original container, protected from moisture and direct sunlight.

Chlorhexidine gluconate can interact with certain substances, affecting its safety or efficacy.

Major Interactions (Avoid): - Aminoglycoside ototoxicity: concurrent use in the ear may increase risk of hearing loss. - Alcohol-based products: mixing can enhance skin irritation and reduce antiseptic effectiveness. - Latex medical devices: may trigger allergic reactions in latex‑sensitive individuals.

Moderate Interactions (Monitor Closely): - Other topical antiseptics: combined use may cause cumulative irritation. - Antifungal agents: potential antagonism reducing antifungal activity. - Systemic antibiotics: no direct interaction, but monitor for overlapping hypersensitivity.